Home › Major Depressive Disorder › New Jersey › Camden
Major Depressive Disorder clinical trials in Camden, NJ
6 studies for Major Depressive Disorder are looking for participants at sites in and around Camden (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
RecruitingPhase 3
- Lumina Clinical Research Center, Cherry Hill · 5 mi away
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
RecruitingPhase 3
- CenExel Marlton NJ, Marlton · 11 mi away
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
RecruitingPhase 2
- Draig Clinical Site, Marlton · 11 mi away
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
RecruitingPhase 3
- Clinical Research Site, Cherry Hill · 5 mi away
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
RecruitingPhase 2
- Autobahn Site #129, Berlin · 14 mi away
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
RecruitingPhase 4
- Clinical Research Site, Cherry Hill · 5 mi away
Major Depressive Disorder trials in other cities
- New York City, NY37 studies
- Boston, MA30 studies
- Atlanta, GA24 studies
- Philadelphia, PA22 studies
- Orlando, FL19 studies
- Tampa, FL17 studies
- Miami, FL17 studies
- Chicago, IL16 studies
- Houston, TX16 studies
- San Diego, CA16 studies
- Little Rock, AR14 studies
- Austin, TX13 studies
Other studies in Camden
- Non-Small Cell Lung Cancer11 studies
- Schizophrenia10 studies
- Lung Cancer9 studies
- Heart Failure8 studies
- Breast Cancer8 studies
- Cardiovascular Disease6 studies
- Endometrial Cancer6 studies
- Cancer (all types)6 studies
- Coronary Artery Disease6 studies
- Ovarian Cancer6 studies
- High Blood Pressure5 studies
- COPD5 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.